Semaglutide Shows Potential to Slow Aging and Reduce Mortality Rates

New research highlights the broad health benefits of the weight-loss drug, including lower death rates from cardiovascular issues and COVID-19.

Studies indicate semaglutide reduces inflammation and improves heart health, regardless of weight loss.
Participants in trials had lower all-cause mortality rates, including from cardiovascular diseases and infections.
The drug mimics a hormone that helps control appetite and blood sugar, making users feel fuller.
Researchers suggest the drug could treat various conditions linked to inflammation, such as Alzheimer's and cancer.
Experts caution that semaglutide should be used under medical supervision due to potential side effects.